STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Ayrton, Alto Fund and W. Khatri Disclose 2,000 IMNN Shares Issuable

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Imunon, Inc. received a Schedule 13G/A reporting that three related reporting persons — Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) and individual Waqas Khatri — each beneficially own 2,000 shares of the issuer's common stock that are issuable on the exercise of certain warrants and conversion of certain convertible notes. The filing states these holdings represent 0.01% each based on 17,541,732 shares outstanding cited in the issuer's registration statement prior to a July 2025 reverse stock split.

The filing notes the warrants are subject to a 9.99% beneficial ownership blocker and includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

Positive

  • Clear, specific disclosure of the number of issuable shares (2,000) and the pre-split outstanding share base (17,541,732)
  • Certification that the securities are held in the ordinary course and not to change or influence control
  • Beneficial ownership blocker (9.99%) limits near-term accumulation risk from the warrants

Negative

  • None.

Insights

TL;DR: Small, non-control positions; limited market impact; potential dilution exists but immaterial at reported scale.

The three reporting persons each hold rights to 2,000 shares, equivalent to 0.01% of the cited 17,541,732 outstanding shares (pre-reverse-split basis). These are issuable on exercise/conversion of warrants and notes, so they represent potential dilution rather than current voting stock. The presence of a 9.99% beneficial ownership blocker limits immediate accumulation risk. Overall, at this scale the holdings are immaterial to market capitalization or governance and are unlikely to move pricing or influence strategic decisions.

TL;DR: Filing shows compliance and clarifies no intent to influence control; governance risk is minimal.

The disclosure identifies the investment manager, fund vehicle and the individual managing member as reporting persons and states the securities are held in the ordinary course of business with no intent to affect control. The filing documents sole voting and dispositive power over the reported 2,000 issuable shares for each filer and notes the 9.99% ownership blocker on the warrant-related shares. From a governance perspective this is a routine transparency filing with no apparent control implications.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Ayrton Capital LLC
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri / Managing Member
Date:08/13/2025
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri / Director
Date:08/13/2025
Waqas Khatri
Signature:/s/ Waqas Khatri
Name/Title:Waqas Khatri
Date:08/13/2025

FAQ

How many IMNN shares do the reporting persons beneficially own?

Each reporting person reports beneficial ownership of 2,000 shares issuable on the exercise of warrants and conversion of convertible notes.

What percentage of IMNN does 2,000 shares represent?

0.01% of the 17,541,732 shares outstanding referenced in the filing (pre-reverse-split basis).

Are the reported IMNN shares currently outstanding or issuable?

The reported shares are issuable upon exercise of certain warrants and conversion of certain convertible notes, not currently counted as outstanding shares held by the filers.

Is there any ownership limit or blocker on the reported shares?

Yes. The filing states the shares related to the exercise of the warrants are subject to a 9.99% beneficial ownership blocker.

Did the filers state intent to influence control of Imunon (IMNN)?

No. The filers certified the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Imunon Inc

NASDAQ:IMNN

IMNN Rankings

IMNN Latest News

IMNN Latest SEC Filings

IMNN Stock Data

11.85M
3.04M
1.55%
7.74%
4.54%
Biotechnology
Pharmaceutical Preparations
Link
United States
LAWRENCEVILLE